Document:

Columbia/HCA Healthcare Corporation 2000 Equity Incentive Plan

 Exhibit 10.6 
 COLUMBIA/HCA HEALTHCARE CORPORATION 
 2000 EQUITY INCENTIVE PLAN 
  

 TABLE OF CONTENTS 
  

					
	 Section 1.
	  	Purpose	  	1
	 Section 2.
	  	Definitions	  	1
	 Section 3.
	  	Administration	  	4
	 Section 4.
	  	Shares Available For Awards	  	5
	 Section 5.
	  	Eligibility	  	6
	 Section 6.
	  	Stock Options And Stock Appreciation Rights	  	6
	 Section 7.
	  	Restricted Shares And Restricted Share Units	  	8
	 Section 8.
	  	Performance Awards	  	9
	 Section 9.
	  	Other Stock-Based Awards	  	10
	 Section 10.
	  	Non-Employee Director And Outside Director Awards	  	10
	 Section 11.
	  	Provisions Applicable To Covered Officers And Performance Awards	  	10
	 Section 12.
	  	Termination Of Employment	  	11
	 Section 13.
	  	Change In Control	  	11
	 Section 14.
	  	Amendment And Termination	  	11
	 Section 15.
	  	General Provisions	  	12
	 Section 16.
	  	Term Of The Plan	  	14

  

 COLUMBIA/HCA HEALTHCARE CORPORATION 
 2000 EQUITY INCENTIVE PLAN 
 SECTION 1. PURPOSE 
 This plan shall be known as the “Columbia/HCA Healthcare Corporation 2000 Equity Incentive Plan” (the “Plan”). The purpose of the Plan is to promote
the interests of Columbia/HCA Healthcare Corporation, a Delaware corporation (the “Company”) and its stockholders by (i) attracting and retaining key officers, employees, and directors of, and consultants to, the Company and its
Subsidiaries and Affiliates; (ii) motivating such individuals by means of performance-related incentives to achieve long-range performance goals, (iii) enabling such individuals to participate in the long-term growth and financial success
of the Company, (iv) encouraging ownership of stock in the Company by such individuals, and (v) linking their compensation to the long-term interests of the Company and its stockholders. With respect to any awards granted under the Plan
that are intended to comply with the requirements of “performance-based compensation” under Section 162(m) of the Code, the Plan shall be interpreted in a manner consistent with such requirements. 
 SECTION 2. DEFINITIONS 
 As used in the Plan, the following terms shall have
the meanings set forth below: 
 (a) “AFFILIATE” shall mean (i) any entity that, directly or indirectly, is controlled by the Company,
(ii) any entity in which the Company has a significant equity interest, (iii) an affiliate of the Company, as defined in Rule 12b-2 promulgated under Section 12 of the Exchange Act, and (iv) any entity in which the Company has at
least twenty percent (20%) of the combined voting power of the entity’s outstanding voting securities, in each case as designated by the Board as being a participating employer in the Plan. 
 (b) “AO OPTION” shall mean an Option to purchase, at Fair Market Value at the date of grant of the AO Option, a number of Shares equal to the sum of the number
of whole Shares delivered by the Option holder in payment of the Option Price of the original Option and the number of whole Shares, if any, withheld by the Company as payment for withholding taxes. 
 (c) “AWARD” shall mean any Option, Stock Appreciation Right, Restricted Share Award, Restricted Share Unit, Performance Award, Other Stock-Based Award or other
award granted under the Plan, whether singly, in combination, or in tandem, to a Participant by the Committee (or the Board) pursuant to such terms, conditions, restrictions and/or limitations, if any, as the Committee (or the Board) may establish.

 (d) “AWARD AGREEMENT” shall mean any written agreement, contract, or other instrument or document evidencing any Award, which may, but need not,
be executed or acknowledged by a Participant. 
 (e) “BOARD” shall mean the board of directors of the Company. 
 (f) “CAUSE” shall mean, unless otherwise defined in the applicable Award Agreement, (i) the engaging by the Participant in willful misconduct that is
injurious to the Company or its Subsidiaries or Affiliates, or (ii) the embezzlement or misappropriation of funds or property of the Company or its Subsidiaries or Affiliates by the Participant. For purposes of this paragraph, no act, or
failure to act, on the Participant’s part shall be considered “willful” unless done, or omitted to be done, by the Participant not in good faith and without reasonable belief that the Participant’s action or omission was in the
best interest of the Company. Any determination of Cause for purposes of the Plan or any Award shall be made by the Committee in its sole discretion. Any such determination shall be final and binding on a Participant. 
 (g) “CHANGE IN CONTROL” shall mean, unless otherwise defined in the applicable Award Agreement, any of the following events: 
 (i) An acquisition (other than directly from the Company) of any voting securities of the Company (the “Voting Securities”) by any “Person” (as the
term Person is used for purposes of Section 13(d) or 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange 
  

 1 

 
Act”)) immediately after which such Person has “Beneficial Ownership” (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of
twenty percent (20%) or more of the combined voting power of the then outstanding Voting Securities; provided, however, that in determining whether a Change in Control has occurred, Voting Securities which are acquired in a “Non-Control
Acquisition” (as hereinafter defined) shall not constitute an acquisition which would cause a Change in Control. A “Non-Control Acquisition” shall mean an acquisition by (i) an employee benefit plan (or a trust forming a part
thereof) maintained by (A) the Company or (B) any Subsidiary or (ii) the Company or any Subsidiary; 
 (ii) The individuals who, as of the
date hereof, are members of the Board (the “Incumbent Board”), cease for any reason to constitute at least two-thirds of the Board; provided, however, that if the election or nomination for election by the Company’s stockholders of
any new director was approved by a vote of at least two-thirds of the Incumbent Board, such new director shall, for purposes of this Agreement, be considered as a member of the Incumbent Board; provided, further, however, that no individual shall be
considered a member of the Incumbent Board if (1) such individual initially assumed office as a result of either an actual or threatened “Election Contest” (as described in Rule 14a-11 promulgated under the Exchange Act) or other
actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board (a “Proxy Contest”) including by reason of any agreement intended to avoid or settle any Election Contest or Proxy Contest or
(2) such individual was designated by a Person who has entered into an agreement with the Company to effect a transaction described in clause (i) or (iii) of this paragraph; or 
 (iii) Approval by stockholders of the Company of: 
 (A) A merger,
consolidation or reorganization involving the Company, unless, 
 (1) The stockholders of the Company, immediately before such merger, consolidation or
reorganization, own, directly or indirectly immediately following such merger, consolidation or reorganization, at least seventy-five percent (75%) of the combined voting power of the outstanding Voting Securities of the corporation (the
“Surviving Corporation”) in substantially the same proportion as their ownership of the Voting Securities immediately before such merger, consolidation or reorganization; 
 (2) The individuals who were members of the Incumbent Board immediately prior to the execution of the agreement providing for such merger, consolidation or reorganization constitute at least two-thirds of the members
of the board of directors of the Surviving Corporation; and 
 (3) no Person (other than the Company, any Subsidiary, any employee benefit plan (or any trust
forming a part thereof) maintained by the Company, the Surviving Corporation or any Subsidiary, or any Person who, immediately prior to such merger, consolidation or reorganization, had Beneficial Ownership of twenty percent (20%) or more of
the then outstanding Voting Securities) has Beneficial Ownership of twenty percent (20%) or more of the combined voting power of the Surviving Corporation’s then outstanding Voting Securities. 
 (B) A complete liquidation or dissolution of the Company; or 
 (C) An
agreement for the sale or other disposition of all or substantially all of the assets of the Company to any Person (other than a transfer to a Subsidiary). 
 Notwithstanding the foregoing, a Change in Control shall not be deemed to occur solely because any Person (the “Subject Person”) acquired Beneficial Ownership of more than the permitted amount of the outstanding Voting Securities
as a result of the acquisition of Voting Securities by the Company which, by reducing the number of Voting Securities outstanding, increased the proportional number of shares Beneficially Owned by the Subject Person, provided that if a Change in
Control would occur (but for the operation of this sentence) as a result of the acquisition of Voting Securities by the Company, and after 

  

 2 

 
such share acquisition by the Company, the Subject Person becomes the Beneficial Owner of any additional Voting Securities Beneficially Owned by the Subject
Person, then a Change in Control shall occur. 
 (h) “CODE” shall mean the Internal Revenue Code of 1986, as amended from time to time. 

(i) “COMMITTEE” shall mean a committee of the Board composed of not less than two Non-Employee Directors, each of whom shall be a “Non-Employee
Director” for purposes of Exchange Act Section 16 and Rule 16b-3 thereunder and an “outside director” for purposes of Section 162(m) and the regulations promulgated under the Code. 
 (j) “CONSULTANT” shall mean any consultant to the Company or its Subsidiaries or Affiliates. 
 (k) “COVERED OFFICER” shall mean at any date (i) any individual who, with respect to the previous taxable year of the Company, was a “covered employee” of the Company within the meaning of
Section 162(m); provided, however, that the term “Covered Officer” shall not include any such individual who is designated by the Committee, in its discretion, at the time of any Award or at any subsequent time, as reasonably expected
not to be such a “covered employee” with respect to the current taxable year of the Company and (ii) any individual who is designated by the Committee, in its discretion, at the time of any Award or at any subsequent time, as
reasonably expected to be such a “covered employee” with respect to the current taxable year of the Company or with respect to the taxable year of the Company in which any applicable Award will be paid. 
 (l) “DIRECTOR” shall mean a member of the Board. 
 (m)
“DISABILITY” shall mean, unless otherwise defined in the applicable Award Agreement, a disability that would qualify as a total and permanent disability under the Company’s then current long-term disability plan. 
 (n) “EMPLOYEE” shall mean a current or prospective officer or employee of the Company or of any Subsidiary or Affiliate. 
 (o) “EXCHANGE ACT” shall mean the Securities Exchange Act of 1934, as amended from time to time. 
 (p) “FAIR MARKET VALUE” with respect to the Shares, shall mean, for purposes of a grant of an Award as of any date, (i) the closing sales price of the Shares on the New York Stock Exchange, or any other
such exchange on which the shares are traded, on such date, or in the absence of reported sales on such date, the closing sales price on the immediately preceding date on which sales were reported or (ii) in the event there is no public market
for the Shares on such date, the fair market value as determined, in good faith, by the Committee in its sole discretion, and for purposes of a sale of a Share as of any date, the actual sales price on that date. 
 (q) “INCENTIVE STOCK OPTION” shall mean an option to purchase Shares from the Company that is granted under Section 6 of the Plan and that is intended to
meet the requirements of Section 422 of the Code or any successor provision thereto. 
 (r) “NON-QUALIFIED STOCK OPTION” shall mean an option
to purchase Shares from the Company that is granted under Sections 6 or 10 of the Plan and is not intended to be an Incentive Stock Option. 
 (s)
“NON-EMPLOYEE DIRECTOR” shall mean a member of the Board who is not an officer or employee of the Company or any Subsidiary or Affiliate. 
 (t)
“OPTION” shall mean an Incentive Stock Option or a Non-Qualified Stock Option. 
 (u) “OPTION PRICE” shall mean the purchase price
payable to purchase one Share upon the exercise of an Option. 
 (v) “OTHER STOCK-BASED AWARD” shall mean any Award granted under Sections 9 or 10
of the Plan. 
  

 3 

 (w) “OUTSIDE DIRECTOR” means, with respect to the grant of an Award, a member of the Board then serving on the
Committee. 
 (x) “PARTICIPANT” shall mean any Employee, Director, Consultant or other person who receives an Award under the Plan. 
 (y) “PERFORMANCE AWARD” shall mean any Award granted under Section 8 of the Plan. 
 (z) “PERSON” shall mean any individual, corporation, partnership, limited liability company, associate, joint-stock company, trust, unincorporated organization, government or political subdivision thereof or
other entity. 
 (aa) “RESTRICTED SHARE” shall mean any Share granted under Sections 7 or 10 of the Plan. 
 (bb) “RESTRICTED SHARE UNIT” shall mean any unit granted under Sections 7 or 10 of the Plan. 
 (cc) “RETIREMENT” shall mean, unless otherwise defined in the applicable Award Agreement, retirement of a Participant from the employ or service of the Company or any of its Subsidiaries or Affiliates in
accordance with the terms of the applicable Company retirement plan or, if a Participant is not covered by any such plan, retirement on or after such Participant’s 65th birthday. 
 (dd) “SEC” shall mean the Securities and Exchange Commission or any successor thereto. 
 (ee) “SECTION
16” shall mean Section 16 of the Exchange Act and the rules promulgated thereunder and any successor provision thereto as in effect from time to time. 
 (ff) “SECTION 162(M)” shall mean Section 162(m) of the Code and the regulations promulgated thereunder and any successor or provision thereto as in effect from time to time. 
 (gg) “SHARES” shall mean shares of the common stock, $0.01 par value, of the Company. 
 (hh) “STOCK APPRECIATION RIGHT OR SAR” shall mean a stock appreciation right granted under Sections 6 or 10 of the Plan that entitles the holder to receive, with respect to each Share encompassed by the
exercise of such SAR, the amount determined by the Committee and specified in an Award Agreement. In the absence of such a determination, the holder shall be entitled to receive, with respect to each Share encompassed by the exercise of such SAR,
the excess of the Fair Market Value on the date of exercise over the Fair Market Value on the date of grant. 
 (ii) “SUBSIDIARY” shall mean any
Person (other than the Company) of which a majority of its voting power or its equity securities or equity interest is owned directly or indirectly by the Company. 
 (jj) “SUBSTITUTE AWARDS” shall mean Awards granted solely in assumption of, or in substitution for, outstanding awards previously granted by a company acquired by the Company or with which the Company combines. 
 (kk) “TANDEM SAR” shall mean an SAR that is granted under Sections 6 or 10 of the Plan in relation to a particular Option and that can be exercised only upon
the surrender to the Company, unexercised, of that portion of the Option to which the SAR relates. 
 SECTION 3. ADMINISTRATION 
 3.1 Authority of Committee. The Plan shall be administered by the Committee, which shall be appointed by and serve at the pleasure of the Board; provided, however, with
respect to Awards to Outside Directors, all references in the Plan to the Committee shall be deemed to be references to the Board. Subject to the terms of the Plan and applicable law, and in addition to other express powers and authorizations
conferred on the Committee by the Plan, the Committee shall have full power and authority in its discretion to: (i) designate Participants; (ii) determine the type or types of Awards to be granted to a Participant; (iii) determine the
number of Shares to be covered by, or with respect to which payments, rights, or other matters are to be calculated in connection with Awards; (iv) determine the timing, terms, and conditions of 
  

 4 

 
any Award; (v) accelerate the time at which all or any part of an Award may be settled or exercised; (vi) determine whether, to what extent, and
under what circumstances Awards may be settled or exercised in cash, Shares, other securities, other Awards or other property, or canceled, forfeited, or suspended and the method or methods by which Awards may be settled, exercised, canceled,
forfeited, or suspended; (vii) determine whether, to what extent, and under what circumstances cash, Shares, other securities, other Awards, other property, and other amounts payable with respect to an Award shall be deferred either
automatically or at the election of the holder thereof or of the Committee; (viii) interpret and administer the Plan and any instrument or agreement relating to, or Award made under, the Plan; (ix) except to the extent prohibited by
Section 6.2, amend or modify the terms of any Award at or after grant with the consent of the holder of the Award; (x) establish, amend, suspend, or waive such rules and regulations and appoint such agents as it shall deem appropriate for
the proper administration of the Plan; and (xi) make any other determination and take any other action that the Committee deems necessary or desirable for the administration of the Plan, subject to the exclusive authority of the Board under
Section 14 hereunder to amend or terminate the Plan. 
 3.2 Committee Discretion Binding. Unless otherwise expressly provided in the Plan, all
designations, determinations, interpretations, and other decisions under or with respect to the Plan or any Award shall be within the sole discretion of the Committee, may be made at any time and shall be final, conclusive, and binding upon all
Persons, including the Company, any Subsidiary or Affiliate, any Participant and any holder or beneficiary of any Award. 
 3.3 Action by the Committee. The
Committee shall select one of its members as its Chairperson and shall hold its meetings at such times and places and in such manner as it may determine. A majority of its members shall constitute a quorum. All determinations of the Committee shall
be made by not less than a majority of its members. Any decision or determination reduced to writing and signed by all of the members of the Committee shall be fully effective as if it had been made by a majority vote at a meeting duly called and
held. The exercise of an Option or receipt of an Award shall be effective only if an Award Agreement shall have been duly executed and delivered on behalf of the Company following the grant of the Option or other Award. The Committee may appoint a
Secretary and may make such rules and regulations for the conduct of its business as it shall deem advisable. 
 3.4 Delegation. Subject to the terms of the
Plan and applicable law, the Committee may delegate to one or more officers or managers of the Company or of any Subsidiary or Affiliate, or to a Committee of such officers or managers, the authority, subject to such terms and limitations as the
Committee shall determine, to grant Awards to, or to cancel, modify or waive rights with respect to, or to alter, discontinue, suspend, or terminate Awards held by Participants who are not officers or directors of the Company for purposes of
Section 16 or who are otherwise not subject to such Section. 
 3.5 No Liability. No member of the Board or Committee shall be liable for any action
taken or determination made in good faith with respect to the Plan or any Award granted hereunder. 
 SECTION 4. SHARES AVAILABLE FOR AWARDS 
 4.1 Shares Available. Subject to the provisions of Section 4.2 hereof, the stock to be subject to Awards under the Plan shall be the Shares of the Company and the
maximum number of Shares with respect to which Awards may be granted under the Plan shall be 50,500,000 (which includes 500,000 Shares with respect to which awards under the Amended and Restated Columbia/HCA Healthcare Corporation 1992 Stock and
Incentive Plan (the “1992 Plan”) were authorized but not granted), of which (i) the number of Shares with respect to which Incentive Stock Options may be granted shall be no more than 50,500,000 and (ii) no more than 10,000,000
shall be Shares with respect to which Awards other than Options may be granted. Notwithstanding the foregoing and subject to adjustment as provided in Section 4.2, the maximum number of Shares with respect to which Awards may be granted under
the Plan shall be increased by the number of Shares with respect to which Options or other Awards were granted under the 1992 Plan as of the effective date of this Plan, but which terminate, expire unexercised, or are settled for cash, forfeited or
cancelled without the delivery of Shares under the terms of the 1992 Plan after the effective date of this Plan. 
  

 5 

 If, after the effective date of the Plan, any Shares covered by an Award granted under this Plan, or to which such an
Award relates, are forfeited, or if such an Award is settled for cash or otherwise terminates, expires unexercised, or is canceled without the delivery of Shares, then the Shares covered by such Award, or to which such Award relates, or the number
of Shares otherwise counted against the aggregate number of Shares with respect to which Awards may be granted, to the extent of any such settlement, forfeiture, termination, expiration, or cancellation, shall again become Shares with respect to
which Awards may be granted. In the event that any Option or other Award granted hereunder is exercised through the delivery of Shares or in the event that withholding tax liabilities arising from such Award are satisfied by the withholding of
Shares by the Company, the number of Shares available for Awards under the Plan shall be increased by the number of Shares so surrendered or withheld. Notwithstanding the foregoing and subject to adjustment as provided in Section 4.2 hereof, no
Participant may receive Options or SARs under the Plan in any calendar year that relate to more than 2,000,000 Shares. 
 4.2 Adjustments. In the event that
the Committee determines that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up,
spin-off, combination, repurchase, or exchange of Shares or other securities of the Company, issuance of warrants or other rights to purchase Shares or other securities of the Company, or other similar corporate transaction or event affects the
Shares such that an adjustment is determined by the Committee, in its sole discretion, to be appropriate, then the Committee shall, in such manner as it may deem equitable (and, with respect to Incentive Stock Options, in such manner as is
consistent with Section 422 of the Code and the regulations thereunder): (i) adjust any or all of (1) the aggregate number of Shares or other securities of the Company (or number and kind of other securities or property) with respect
to which Awards may be granted under the Plan; (2) the number of Shares or other securities of the Company (or number and kind of other securities or property) subject to outstanding Awards under the Plan; and (3) the grant or exercise
price with respect to any Award under the Plan, provided that the number of shares subject to any Award shall always be a whole number; (ii) if deemed appropriate, provide for an equivalent award in respect of securities of the surviving entity
of any merger, consolidation or other transaction or event having a similar effect; or (iii) if deemed appropriate, make provision for a cash payment to the holder of an outstanding Award. 
 4.3 Substitute Awards. Any Shares issued by the Company as Substitute Awards in connection with the assumption or substitution of outstanding grants from any acquired
corporation shall not reduce the Shares available for Awards under the Plan. 
 4.4 Sources of Shares Deliverable Under Awards. Any Shares delivered pursuant
to an Award may consist, in whole or in part, of authorized and unissued Shares or of issued Shares which have been reacquired by the Company 
 SECTION 5.
ELIGIBILITY 
 Any Employee, Director or Consultant shall be eligible to be designated a Participant; provided, however, that Outside Directors shall only be
eligible to receive Awards granted consistent with Section 10. 
 SECTION 6. STOCK OPTIONS AND STOCK APPRECIATION RIGHTS 
 6.1 Grant. Subject to the provisions of the Plan, the Committee shall have sole and complete authority to determine the Participants to whom Options and SARs shall be
granted, the number of Shares subject to each Award, the exercise price and the conditions and limitations applicable to the exercise of each Option and SAR. An Option may be granted with or without a Tandem SAR. An SAR may be granted with or
without a related Option. The Committee shall have the authority to grant Incentive Stock Options, or to grant Non-Qualified Stock Options, or to grant both types of Options. In the case of Incentive Stock Options or Tandem SARs related to such
Options, the terms and conditions of such grants shall be subject to and comply with such rules as may be prescribed by Section 422 of the Code, as from time to time amended, and any regulations implementing such statute. A person who has been
granted an Option or SAR under this Plan may be granted additional Options or SARs under the Plan if the Committee shall so determine; provided, 

  

 6 

 
however, that to the extent the aggregate Fair Market Value (determined at the time the Incentive Stock Option or Tandem SAR related thereto is granted) of
the Shares with respect to which all Incentive Stock Options or Tandem SARs related to such Option are exercisable for the first time by an Employee during any calendar year (under all plans described in subsection (d) of Section 422 of
the Code of the Employee’s employer corporation and its parent and Subsidiaries) exceeds $100,000, such Options shall be treated as Non-Qualified Stock Options. 
 6.2 Price. The Committee in its sole discretion shall establish the Option Price at the time each Option is granted. Except in the case of Substitute Awards, the Option Price of an Option may not be less than 100% of
the Fair Market Value of the Shares with respect to which the Option is granted on the date of grant of such Option. Notwithstanding the foregoing and except as permitted by the provisions of Section 4.2 and Section 14 hereof, the
Committee shall not have the power to (i) amend the terms of previously granted Options to reduce the Option Price of such Options, or (ii) cancel such Options and grant substitute Options with a lower Option Price than the cancelled
Options. Except with respect to Substitute Awards, SARs may not be granted at a price less than the Fair Market Value of a Share on the date of grant. 
 6.3
Term. Subject to the Committee’s authority under Section 3.1 and the provisions of Section 6.6, each Option and SAR and all rights and obligations thereunder shall expire on the date determined by the Committee and specified in the
Award Agreement. The Committee shall be under no duty to provide terms of like duration for Options or SARs granted under the Plan. Notwithstanding the foregoing, no Option or Tandem SAR that relates to such Option shall be exercisable after the
expiration of ten (10) years from the date such Option or SAR was granted. 
 6.4 Exercise. 
 (a) Each Option and SAR shall be exercisable at such times and subject to such terms and conditions as the Committee may, in its sole discretion, specify in the
applicable Award Agreement or thereafter. The Committee shall have full and complete authority to determine, subject to Section 6.6 herein, whether an Option or SAR will be exercisable in full at any time or from time to time during the term of
the Option or SAR, or to provide for the exercise thereof in such installments, upon the occurrence of such events and at such times during the term of the Option or SAR as the Committee may determine. 
 (b) The Committee may impose such conditions with respect to the exercise of Options, including without limitation, any relating to the application of federal, state or
foreign securities laws or the Code, as it may deem necessary or advisable. The exercise of any Option granted hereunder shall be effective only at such time as the sale of Shares pursuant to such exercise will not violate any state or federal
securities or other laws. 
 (c) An Option or SAR may be exercised in whole or in part at any time, with respect to whole Shares only, within the period
permitted thereunder for the exercise thereof, and shall be exercised by written notice of intent to exercise the Option or SAR, delivered to the Company at its principal office, and payment in full to the Company at the direction of the Committee
of the amount of the Option Price for the number of Shares with respect to which the Option is then being exercised. A Tandem SAR that is related to an Incentive Stock Option may be exercised only to the extent that the related Option is exercisable
and only when the Fair Market Value exceeds the Option Price of the related Option. The exercise of either an Option or Tandem SAR shall result in the termination of the other to the extent of the number of Shares with respect to which either the
Option or Tandem SAR is exercised. 
 (d) Payment of the Option Price shall be made in cash or cash equivalents, or, at the discretion of the Committee,
(i) in whole Shares valued at the Fair Market Value of such Shares on the date of exercise (or next succeeding trading date, if the date of exercise is not a trading date), together with any applicable withholding taxes, or (ii) by a
combination of such cash (or cash equivalents) and such Shares; provided, however, that the optionee shall not be entitled to tender Shares pursuant to successive, substantially simultaneous exercises of an Option or any other stock option of the
Company. Subject to applicable securities laws, an Option may also be exercised by delivering a notice of exercise of the 

  

 7 

 
Option and simultaneously selling the Shares thereby acquired, pursuant to a brokerage or similar agreement approved in advance by proper officers of the
Company, using the proceeds of such sale as payment of the Option Price, together with any applicable withholding taxes. Until the optionee has been issued the Shares subject to such exercise, he or she shall possess no rights as a stockholder with
respect to such Shares. 
 (e) At the Committee’s discretion, the amount payable as a result of the exercise of an SAR may be settled in cash, Shares,
or a combination of cash and Shares. A fractional Share shall not be deliverable upon the exercise of a SAR but a cash payment will be made in lieu thereof. 
 6.5 Accelerated Ownership Feature. An Option may, in the discretion of the Committee, include the right to acquire an AO Option. An Option which provides for the grant of an AO Option shall entitle the Option holder upon exercise of that
Option and payment of the appropriate Option Price in Shares that have been owned by such Option holder for not less than six (6) months prior to the date of exercise, to receive an AO Option. An AO Option shall expire on the same date that the
original Option would have expired had it not been exercised. All AO Options shall be Non-Qualified Stock Options. 
 6.6 Ten Percent Stock Rule.
Notwithstanding any other provisions in the Plan, if at the time an Option or SAR is otherwise to be granted pursuant to the Plan the optionee or rights holder owns directly or indirectly (within the meaning of Section 424(d) of the Code)
Shares of the Company possessing more than ten percent (10%) of the total combined voting power of all classes of Stock of the Company or its parent or Subsidiary or Affiliate corporations (within the meaning of Section 422(b)(6) of the
Code), then any Incentive Stock Option or Tandem SAR to be granted to such optionee or rights holder pursuant to the Plan shall satisfy the requirement of Section 422(c)(5) of the Code, and the Option Price shall be not less than 110% of the
Fair Market Value of the Shares of the Company, and such Option by its terms shall not be exercisable after the expiration of five (5) years from the date such Option is granted. 
 SECTION 7. RESTRICTED SHARES AND RESTRICTED SHARE UNITS 
 7.1 Grant. 
 (a) Subject to the provisions of the Plan, the Committee shall have sole and complete authority to determine the Participants to whom Restricted Shares and Restricted
Share Units shall be granted, the number of Restricted Shares and/or the number of Restricted Share Units to be granted to each Participant, the duration of the period during which, and the conditions under which, the Restricted Shares and
Restricted Share Units may be forfeited to the Company, and the other terms and conditions of such Awards. The Restricted Share and Restricted Share Unit Awards shall be evidenced by Award Agreements in such form as the Committee shall from time to
time approve, which agreements shall comply with and be subject to the terms and conditions provided hereunder and any additional terms and conditions established by the Committee that are consistent with the terms of the Plan. 
 (b) Each Restricted Share and Restricted Share Unit Award made under the Plan shall be for such number of Shares as shall be determined by the Committee and set forth in
the Award Agreement containing the terms of such Restricted Share or Restricted Share Unit Award. Such agreement shall set forth a period of time during which the grantee must remain in the continuous employment of the Company in order for the
forfeiture and transfer restrictions to lapse. If the Committee so determines, the restrictions may lapse during such restricted period in installments with respect to specified portions of the Shares covered by the Restricted Share or Restricted
Share Unit Award. The Award Agreement may also, in the discretion of the Committee, set forth performance or other conditions that will subject the Shares to forfeiture and transfer restrictions. The Committee may, at its discretion, waive all or
any part of the restrictions applicable to any or all outstanding Restricted Share and Restricted Share Unit Awards. 
 7.2 Delivery of Shares and Transfer
Restrictions. At the time of a Restricted Share Award, a certificate representing the number of Shares awarded thereunder shall be registered in the name of the grantee. Such certificate shall be held by the Company or any custodian appointed by the
Company for the account of the grantee subject to the terms and conditions of the Plan, and shall bear such a legend setting 

  

 8 

 
forth the restrictions imposed thereon as the Committee, in its discretion, may determine. The grantee shall have all rights of a stockholder with respect to
the Restricted Shares, including the right to receive dividends and the right to vote such Shares, subject to the following restrictions: (i) the grantee shall not be entitled to delivery of the stock certificate until the expiration of the
restricted period and the fulfillment of any other restrictive conditions set forth in the Award Agreement with respect to such Shares; (ii) none of the Shares may be sold, assigned, transferred, pledged, hypothecated or otherwise encumbered or
disposed of during such restricted period or until after the fulfillment of any such other restrictive conditions; and (iii) except as otherwise determined by the Committee at or after grant, all of the Shares shall be forfeited and all rights
of the grantee to such Shares shall terminate, without further obligation on the part of the Company, unless the grantee remains in the continuous employment of the Company for the entire restricted period in relation to which such Shares were
granted and unless any other restrictive conditions relating to the Restricted Share Award are met. Any Shares, any other securities of the Company and any other property (except for cash dividends) distributed with respect to the Shares subject to
Restricted Share Awards shall be subject to the same restrictions, terms and conditions as such restricted Shares. 
 7.3 Termination of Restrictions. At the
end of the restricted period and provided that any other restrictive conditions of the Restricted Share Award are met, or at such earlier time as otherwise determined by the Committee, all restrictions set forth in the Award Agreement relating to
the Restricted Share Award or in the Plan shall lapse as to the restricted Shares subject thereto, and a stock certificate for the appropriate number of Shares, free of the restrictions and restricted stock legend, shall be delivered to the
Participant or the Participant’s beneficiary or estate, as the case may be. 
 7.4 Payment of Restricted Share Units. Each Restricted Share Unit shall
have a value equal to the Fair Market Value of a Share. Restricted Share Units shall be paid in cash, Shares, other securities or other property, as determined in the sole discretion of the Committee, upon the lapse of the restrictions applicable
thereto, or otherwise in accordance with the applicable Award Agreement. A Participant shall be credited with dividend equivalents on any vested Restricted Share Units credited to the Participant’s account at the time of any payment of
dividends to stockholders on Shares. The amount of any such dividend equivalents shall equal the amount that would have been payable to the Participant as a stockholder in respect of a number of Shares equal to the number of vested Restricted Share
Units then credited to the Participant. Any such dividend equivalents shall be credited to the Participant’s account as of the date on which such dividend would have been payable and shall be converted into additional Restricted Share Units
(which shall be immediately vested) based upon the Fair Market Value of a Share on the date of such crediting. No dividend equivalents shall be paid in respect of Restricted Share Units that are not yet vested. Except as otherwise determined by the
Committee at or after grant, Restricted Share Units may not be sold, assigned, transferred, pledged, hypothecated or otherwise encumbered or disposed of, and all Restricted Share Units and all rights of the grantee to such Restricted Share Units
shall terminate, without further obligation on the part of the Company, unless the grantee remains in continuous employment of the Company for the entire restricted period in relation to which such Restricted Share Units were granted and unless any
other restrictive conditions relating to the Restricted Share Unit Award are met. 
 SECTION 8. PERFORMANCE AWARDS 
 8.1 Grant. The Committee shall have sole and complete authority to determine the Participants who shall receive a Performance Award, which shall consist of a right that
is (i) denominated in cash or Shares, (ii) valued, as determined by the Committee, in accordance with the achievement of such performance goals during such performance periods as the Committee shall establish, and (iii) payable at
such time and in such form as the Committee shall determine. All Performance Awards shall be subject to the terms and provisions of Section 11 hereof. 
 8.2 Terms and Conditions. Subject to the terms of the Plan and any applicable Award Agreement, the Committee shall determine the performance goals to be achieved during any performance period, the length of any performance period, the
amount of any Performance Award and the amount and kind of any payment or transfer to be made pursuant to any Performance Award, and may amend specific provisions of the 

  

 9 

 
Performance Award; provided, however, that such amendment may not adversely affect existing Performance Awards made within a performance period commencing
prior to implementation of the amendment. 
 8.3 Payment of Performance Awards. Performance Awards may be paid in a lump sum or in installments following the
close of the performance period or, in accordance with the procedures established by the Committee, on a deferred basis. Termination of employment prior to the end of any performance period, other than for reasons of death or Disability, will result
in the forfeiture of the Performance Award, and no payments will be made. A Participant’s rights to any Performance Award may not be sold, assigned, transferred, pledged, hypothecated or otherwise encumbered or disposed of in any manner, except
by will or the laws of descent and distribution, and/or except as the Committee may determine at or after grant. 
 SECTION 9. OTHER STOCK-BASED AWARDS

 The Committee shall have the authority to determine the Participants who shall receive an Other Stock-Based Award, which shall consist of any right that is
(i) not an Award described in Sections 6 and 7 above and (ii) an Award of Shares or an Award denominated or payable in, valued in whole or in part by reference to, or otherwise based on or related to, Shares (including, without limitation,
securities convertible into Shares), as deemed by the Committee to be consistent with the purposes of the Plan. Subject to the terms of the Plan and any applicable Award Agreement, the Committee shall determine the terms and conditions of any such
Other Stock-Based Award. 
 SECTION 10. NON-EMPLOYEE DIRECTOR AND OUTSIDE DIRECTOR AWARDS 
 10.1 The Board may provide that all or a portion of a Non-Employee Director’s annual retainer, meeting fees and/or other awards or compensation as determined by the Board, be payable (either automatically or at
the election of a Non-Employee Director) in the form of Non-Qualified Stock Options, Restricted Shares, Restricted Share Units and/or Other Stock-Based Awards, including unrestricted Shares. The Board shall determine the terms and conditions of any
such Awards, including the terms and conditions which shall apply upon a termination of the Non-Employee Director’s service as a member of the Board, and shall have full power and authority in its discretion to administer such Awards, subject
to the terms of the Plan and applicable law. 
 10.2 The Board may also grant Awards to Outside Directors pursuant to the terms of the Plan, including any
Award described in Sections 6, 7 and 9 above. With respect to such Awards, all references in the Plan to the Committee shall be deemed to be references to the Board. 
 SECTION 11. PROVISIONS APPLICABLE TO COVERED OFFICERS AND PERFORMANCE AWARDS 
 11.1 Notwithstanding anything in the Plan to
the contrary, Performance Awards shall be subject to the terms and provisions of this Section 11. 
 11.2 The Committee may grant Performance Awards to
Covered Officers based solely upon the attainment of performance targets related to one or more performance goals selected by the Committee from among the goals specified below. For the purposes of this Section 11, performance goals shall be
limited to one or more of the following Company, Subsidiary, operating unit or division financial performance measures: 
 (a) earnings before interest,
taxes, depreciation and/or amortization; 
 (b) operating income or profit; 
 (c) operating efficiencies; 
 (d) return on equity, assets, capital, capital employed, or investment; 
 (e) after tax operating income; 
 (f) net income; 
 (g) earnings or book value per Share; 
 (h) cash flow(s); 
  

 10 

 (i) total sales or revenues or sales or revenues per employee; 
 (j) production (separate work units or SWUs); 
 (k) stock price or total
shareholder return; 
 (l) dividends; or 
 (m) strategic
business objectives, consisting of one or more objectives based on meeting specified cost targets, business expansion goals, and goals relating to acquisitions or divestitures; 
 or any combination thereof. Each goal may be expressed on an absolute and/or relative basis, may be based on or otherwise employ comparisons based on internal targets, the past performance of the Company or any
Subsidiary, operating unit or division of the Company and/or the past or current performance of other companies, and in the case of earnings-based measures, may use or employ comparisons relating to capital, shareholders’ equity and/or Shares
outstanding, or to assets or net assets. 
 11.3 With respect to any Covered Officer, the maximum annual number of Shares in respect of which all Performance
Awards may be granted under Section 8 of the Plan is 300,000 and the maximum annual amount of any Award settled in cash is $5,000,000. 
 11.4 To the
extent necessary to comply with Section 162(m), with respect to grants of Performance Awards, no later than 90 days following the commencement of each performance period (or such other time as may be required or permitted by Section 162(m)
of the Code), the Committee shall, in writing, (1) select the performance goal or goals applicable to the performance period, (2) establish the various targets and bonus amounts which may be earned for such performance period, and
(3) specify the relationship between performance goals and targets and the amounts to be earned by each Covered Officer for such performance period. Following the completion of each performance period, the Committee shall certify in writing
whether the applicable performance targets have been achieved and the amounts, if any, payable to Covered Officers for such performance period. In determining the amount earned by a Covered Officer for a given performance period, subject to any
applicable Award Agreement, the Committee shall have the right to reduce (but not increase) the amount payable at a given level of performance to take into account additional factors that the Committee may deem relevant to the assessment of
individual or corporate performance for the performance period. 
 SECTION 12. TERMINATION OF EMPLOYMENT 
 The Committee shall have the full power and authority to determine the terms and conditions that shall apply to any Award upon a termination of employment with the
Company, its Subsidiaries and Affiliates, including a termination by the Company with or without Cause, by a Participant voluntarily, or by reason of death, Disability or Retirement, and may provide such terms and conditions in the Award Agreement
or in such rules and regulations as it may prescribe. 
 SECTION 13. CHANGE IN CONTROL 
 Upon a Change in Control, all outstanding Awards shall vest, become immediately exercisable or payable or have all restrictions lifted. 
 SECTION 14. AMENDMENT AND TERMINATION 
 14.1 Amendments to the Plan. The Board may amend, alter, suspend, discontinue, or
terminate the Plan or any portion thereof at any time; provided that no such amendment, alteration, suspension, discontinuation or termination shall be made without stockholder approval if such approval is necessary to comply with any tax or
regulatory requirement for which or with which the Board deems it necessary or desirable to comply. 
 14.2 Amendments to Awards. Subject to the restrictions
of Section 6.2, the Committee may waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, any Award 

  

 11 

 
theretofore granted, prospectively or retroactively; provided that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or
termination that would adversely affect the rights of any Participant or any holder or beneficiary of any Award theretofore granted shall not to that extent be effective without the consent of the affected Participant, holder, or beneficiary.

 14.3 Adjustments of Awards Upon the Occurrence of Certain Unusual or Nonrecurring Events. The Committee is hereby authorized to make adjustments in the
terms and conditions of, and the criteria included in, Awards in recognition of unusual or nonrecurring events (including, without limitation, the events described in Section 4.2 hereof) affecting the Company, any Subsidiary or Affiliate, or
the financial statements of the Company or any Subsidiary or Affiliate, or of changes in applicable laws, regulations, or accounting principles, whenever the Committee determines that such adjustments are appropriate in order to prevent dilution or
enlargement of the benefits or potential benefits intended to be made available under the Plan. 
 SECTION 15. GENERAL PROVISIONS 
 15.1 Limited Transferability of Awards. Except as otherwise provided in the Plan, no Award shall be assigned, alienated, pledged, attached, sold or otherwise transferred
or encumbered by a Participant, except by will or the laws of descent and distribution and/or as may be provided by the Committee in its discretion, at or after grant, in the Award Agreement. No transfer of an Award by will or by laws of descent and
distribution shall be effective to bind the Company unless the Company shall have been furnished with written notice thereof and an authenticated copy of the will and/or such other evidence as the Committee may deem necessary or appropriate to
establish the validity of the transfer. 
 15.2 Dividend Equivalents. In the sole and complete discretion of the Committee, an Award may provide the
Participant with dividends or dividend equivalents, payable in cash, Shares, other securities or other property on a current or deferred basis. All dividend or dividend equivalents which are not paid currently may, at the Committee’s
discretion, accrue interest, be reinvested into additional Shares, or in the case of dividends or dividend equivalents credited in connection with Performance Awards, be credited as additional Performance Awards and paid to the Participant if and
when, and to the extent that, payment is made pursuant to such Award. The total number of Shares available for grant under Section 4 shall not be reduced to reflect any dividends or dividend equivalents that are reinvested into additional
Shares or credited as Performance Awards. 
 15.3 No Rights to Awards. No Person shall have any claim to be granted any Award, and there is no obligation for
uniformity of treatment of Participants or holders or beneficiaries of Awards. The terms and conditions of Awards need not be the same with respect to each Participant. 
 15.4 Share Certificates. All certificates for Shares or other securities of the Company or any Subsidiary or Affiliate delivered under the Plan pursuant to any Award or the exercise thereof shall be subject to such
stop transfer orders and other restrictions as the Committee may deem advisable under the Plan or the rules, regulations and other requirements of the SEC or any state securities commission or regulatory authority, any stock exchange or other market
upon which such Shares or other securities are then listed, and any applicable Federal or state laws, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions. 

15.5 Withholding. A Participant may be required to pay to the Company or any Subsidiary or Affiliate and the Company or any Subsidiary or Affiliate shall have the
right and is hereby authorized to withhold from any Award, from any payment due or transfer made under any Award or under the Plan, or from any compensation or other amount owing to a Participant the amount (in cash, Shares, other securities, other
Awards or other property) of any applicable withholding or other taxes in respect of an Award, its exercise, or any payment or transfer under an Award or under the Plan and to take such other action as may be necessary in the opinion of the Company
to satisfy all obligations for the payment of such taxes. The Committee may provide for additional cash payments to holders of Options to defray or offset any tax arising from the grant, vesting, exercise or payment of any Award. 
  

 12 

 15.6 Award Agreements. Each Award hereunder shall be evidenced by an Award Agreement that shall be delivered to the
Participant and may specify the terms and conditions of the Award and any rules applicable thereto. In the event of a conflict between the terms of the Plan and any Award Agreement, the terms of the Plan shall prevail. 
 15.7 No Limit on Other Compensation Arrangements. Nothing contained in the Plan shall prevent the Company or any Subsidiary or Affiliate from adopting or continuing in
effect other compensation arrangements, which may, but need not, provide for the grant of Options, Restricted Shares, Restricted Share Units, Other Stock-Based Awards or other types of Awards provided for hereunder. 
 15.8 No Right to Employment. The grant of an Award shall not be construed as giving a Participant the right to be retained in the employ of the Company or any Subsidiary
or Affiliate. Further, the Company or a Subsidiary or Affiliate may at any time dismiss a Participant from employment, free from any liability or any claim under the Plan, unless otherwise expressly provided in an Award Agreement. 
 15.9 No Rights as Stockholder. Subject to the provisions of the Plan and the applicable Award Agreement, no Participant or holder or beneficiary of any Award shall have
any rights as a stockholder with respect to any Shares to be distributed under the Plan until such person has become a holder of such Shares. Notwithstanding the foregoing, in connection with each grant of Restricted Shares hereunder, the applicable
Award Agreement shall specify if and to what extent the Participant shall not be entitled to the rights of a stockholder in respect of such Restricted Shares. 
 15.10 Governing Law. The validity, construction and effect of the Plan and any rules and regulations relating to the Plan and any Award Agreement shall be determined in accordance with the laws of the State of Delaware without giving effect
to conflicts of laws principles. 
 15.11 Severability. If any provision of the Plan or any Award is, or becomes, or is deemed to be invalid, illegal, or
unenforceable in any jurisdiction or as to any Person or Award, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to the applicable laws, or if
it cannot be construed or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award, such provision shall be stricken as to such jurisdiction, Person or Award and the remainder of the Plan
and any such Award shall remain in full force and effect. 
 15.12 Other Laws. The Committee may refuse to issue or transfer any Shares or other
consideration under an Award if, acting in its sole discretion, it determines that the issuance or transfer of such Shares or such other consideration might violate any applicable law or regulation (including applicable non-U.S. laws or regulations)
or entitle the Company to recover the same under Exchange Act Section 16(b), and any payment tendered to the Company by a Participant, other holder or beneficiary in connection with the exercise of such Award shall be promptly refunded to the
relevant Participant, holder, or beneficiary. 
 15.13 No Trust or Fund Created. Neither the Plan nor any Award shall create or be construed to create a
trust or separate fund of any kind or a fiduciary relationship between the Company or any Subsidiary or Affiliate and a Participant or any other Person. To the extent that any Person acquires a right to receive payments from the Company or any
Subsidiary or Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured general creditor of the Company or any Subsidiary or Affiliate. 
 15.14 No Fractional Shares. No fractional Shares shall be issued or delivered pursuant to the Plan or any Award, and the Committee shall determine whether cash, other securities, or other property shall be paid or
transferred in lieu of any fractional Shares or whether such fractional Shares or any rights thereto shall be canceled, terminated or otherwise eliminated. 
  

 13 

 15.15 Headings. Headings are given to the sections and subsections of the Plan solely as a convenience to facilitate
reference. Such headings shall not be deemed in any way material or relevant to the construction or interpretation of the Plan or any provision thereof. 
 SECTION 16. TERM OF THE PLAN 
 16.1 Effective Date. The Plan shall be effective as of May 25, 2000 provided it has been approved by the Board
and by the Company’s stockholders. 
 16.2 Expiration Date. No new Awards shall be granted under the Plan after the tenth (10th) anniversary of the
Effective Date. Unless otherwise expressly provided in the Plan or in an applicable Award Agreement, any Award granted hereunder may, and the authority of the Board or the Committee to amend, alter, adjust, suspend, discontinue, or terminate any
such Award or to waive any conditions or rights under any such Award shall, continue after the tenth (10th) anniversary of the Effective Date. 
  

 14Civil and Administrative Settlement Agreement

 Exhibit 10.17 
 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 I. PARTIES 
 This Civil and Administrative Settlement Agreement (Agreement) is entered into between the following (hereinafter “the Parties”) through their authorized
representatives: the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (OIG-HHS) of the Department of Health and Human Services (HHS); the TRICARE Management Activity
(TMA)(formerly the Office of Civilian Health and Medical Program of the Uniformed Services (OCHAMPUS), through its General Counsel; the Office of Personnel Management (OPM), which administers the Federal Employees Health Benefits Program (FEHBP),
through the United States Attorney’s Office for the District of Columbia; (collectively the “United States”); and HCA - The Healthcare Company, formerly known as Columbia/HCA Healthcare Corporation, on behalf of its predecessors and
current and former affiliates, divisions and subsidiaries (collectively “HCA”). 
 II. PREAMBLE 
 As a preamble to this Agreement, the Parties agree to the following: 
 A. HCA
is a Delaware corporation that through its predecessors and/or its subsidiaries and affiliates operates or has operated over 400 hospitals, over 500 home health agencies, and numerous ancillary health care facilities in at least thirty states.

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 B. Dennis J. Wyman, M.D., Robert K. Rothfeder, M.D., Health Outcomes Technologies, Donald S. McLendon, Tonya M.
Atchison, Randal T. Boston, Sharon Christian, Martha Long, Kristen Kuhn, Pamela Cianci, Mary R. Hampton, Sara Ortega, John W. Schilling, Madelyn Rappaport, J. Watson Maxwell, Francis M. Patton, and Francesco Lanni (the “relators”) filed
qui tam actions in various United States District Courts that are now pending before the District Court for the District of Columbia captioned as follows: 
 (1) U.S. ex rel. Wyman and Rothfeder v. HealthTrust, Columbia/HCA, et al., No. 99 - 3310 (D.D.C.)(formerly D.Utah); 
 (2) U.S. ex rel. Health
Outcomes Technologies v. Columbia Medical Center-East, et al., No. 99 - 3297 (D.D.C.)(formerly E.D.Pa.); 
 (3) U.S. ex rel. McLendon v. Columbia
Healthcare Corp., et al., No. 99-3295 (D.D.C.)(formerly N.D.Ga.); 
 (4) U.S. ex rel. Cianci v. Columbia/HCA Healthcare Corp., et al.,
No. 99-2761-CIV-T-23E (formerly M.D. Fla.); 
 (5) U.S. ex rel. Atchison v. Columbia/HCA Healthcare, Inc., No. 99-2399 (D.D.C.)(formerly M.D.
Tenn.); 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 (6) U.S. ex rel. Atchison v. Columbia/HCA Healthcare, Inc., No. 99-3307 (D.D.C.)(formerly W.D.Tex.); 

(7) U.S. ex rel. Boston v. Columbia/HCA Healthcare Corp., No. 99-3301 (D.D.C.)(formerly N.D. Tex.); 
 (8) U.S. ex rel. Christian, Long and Kuhn v. Columbia/HCA Healthcare Corp., et al., No. 99-3303 (D.D.C.)(formerly S.D. Tex.); 
 (9) U.S. ex rel. Hampton v. Columbia/HCA Healthcare Corp., et al., No. 99-3294 (D.D.C.)(formerly M.D.Ga.); 
 (10) U.S. ex rel. Ortega v. Columbia/HCA Healthcare Corp., et al., No. 99-3305 (D.D.C.)(formerly W.D.Tex.); 
 (11) U.S. ex rel. Schilling v. Columbia/HCA Healthcare Corp., et al., Civ. No. 96-1264-CIV-T-23B (formerly M.D.Fla.); 
 (12) U.S. ex rel. Rappaport v. Hospital Corporation of America et al., Civ. No. 99-3228 (formerly N.D. Ala.); 
 (13) U.S. ex rel. Lanni v. Curative Health Services, Inc. et al., No. 00-2584 (D.D.C.)(formerly S.D.N.Y.). 
 C. HCA submitted or caused to be submitted claims for payment to the Medicare Program (Medicare), Title XVIII of the Social Security Act, 42 U.S.C. ss.ss.1395-1395ggg, the Medicaid Program, 42 U.S.C. ss.ss.1396-1396v;
the TRICARE Program (hereinafter referred to as TRICARE), 10 U.S.C. ss.1071 - 1107,and the FEHBP, 5 U.S.C.ss.ss.8901 et seq. (collectively “the government health care programs”). 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 D. The United States contends that it has certain civil claims under the False Claims Act, 31 U.S.C. ss.3729-33, and
other federal statutes and/or common law doctrines, as specified in Paragraph 2 below, against HCA, for engaging in the following conduct (hereinafter referred to as the “Covered Conduct”). 
 (1) OUTPATIENT LABORATORY BILLING 
 From January 1, 1989 through
December 31, 1997, HCA hospitals identified in Attachment 1 to this Agreement billed the government health care programs for outpatient laboratory tests designated by the CPT Codes in the 80000-89999 range, and by CPT Codes G0058, G0059 and
G0060, without regard for whether they were medically necessary, had been properly ordered by physicians or were being billed appropriately. 
 (2) DRG
UPCODING 
 From January 1, 1990 through December 31, 1997, HCA hospitals identified in Attachment 2 to this Agreement “upcoded” claims to
the government health care programs for inpatient hospital admissions by assigning diagnosis codes that were not supported by physician documentation in the patients’ medical records for the purpose of improperly increasing reimbursement on
inpatient claims submitted for the following Diagnosis Related Groups (DRGs): 076, 079, 087, 121, 124, 132, 138, 316, 416, and 475; and the complication and comorbidity DRGs (“cc” DRGs) identified in Attachment 3 to this Agreement.

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 (3) HOME HEALTH COMMUNITY EDUCATION 
 For cost report years 1994 through 1997, HCA submitted claims to Medicare for reimbursement of costs, including administrative and general costs, that it had allocated to community education activities. In fact, some
of these costs were attributable to nonreimbursable advertising and marketing functions performed by home health community educators, including, but not limited to, patient care coordinators, home care coordinators, community liaisons and community
liaison nurses. The conduct described in this Paragraph does not include claims, if any, submitted to Medicaid, TRICARE or FEHBP. 
 (4) HOME HEALTH BILLING
ISSUES 
 Between January 1, 1995 and December 31, 1998, the HCA-owned home health agencies listed in Attachment 4 to this Agreement submitted
claims to Medicare, Medicaid, and TRICARE (a) for visits to patients who did not qualify for home health services because (i) the patients were not homebound, (ii) there was no medical need for such services, or (iii) there was
no medical need for skilled services; (b) for visits that were not provided; (c) for visits to deliver services that were in fact or should 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 
have been provided by an assisted living facility; (d) for visits that lacked proper physician authorization because (i) the home health agency had
not received physician orders prior to billing for services, (ii) the home health agency had not properly obtained the physician signature, (iii) the home health agency provided the services after expiration of the written order from the
physician; and (e) for visits billed but not documented. The conduct described in this Paragraph does not include claims, if any, submitted to FEHBP. 
 (5) HOME HEALTH MANAGEMENT FEES 
 For cost report years 1993 through 1998, HCA improperly included in Medicare cost reports the management fee costs
related to the acquisition of the Olsten, ResCare, AbleCare, CareOne and Central (a/k/a Simeone Central) home health agencies in Florida, Georgia and Alabama. The costs referred to in this Paragraph include all kickback, related party, undisclosed
rebate and cost report claims relating to these acquisitions, but do not include duplicative services or non-allowable costs included in administrative and general costs not otherwise covered in this release allocated to the acquired agencies. The
conduct described in this Paragraph does not include claims, if any, submitted to Medicaid, TRICARE or FEHBP. 
 E. The United States also contends that it
has certain administrative claims against HCA under the provisions 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 
for permissive exclusion from the Medicare, Medicaid, and other Federal health care programs, 42 U.S.C. ss.1320a-7(b), the provisions for civil monetary
penalties, 42 U.S.C. ss.1320a-7a, permissive exclusion from TRICARE, 32 C.F.R. ss.199.9, and permissive exclusion from FEHBP, 5 U.S.C. ss.8902a and 5 C.F.R. Part 970, for the Covered Conduct. 
 F. The following States (“the States”) contend that they have certain civil claims against HCA for the conduct specified in Paragraphs D (1)(outpatient
laboratory), (2)(DRG upcoding) and (4)(home health billing) above: Alaska, Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Mississippi, Missouri,
Nevada, New Hampshire, New Mexico, North Carolina, Ohio, Oklahoma, Oregon, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wyoming. HCA and the States will execute separate settlement agreements regarding these claims in
exchange for the payment specified in Paragraph 1(b) below. 
 G. The relators identified in Paragraph B above are among those who claim entitlement under 31
U.S.C. ss.3730(d) to a share of the proceeds of this Agreement, but the relators and the United States have not agreed on the entitlement or amount of that award, if any. This Agreement does not cover the claims of any relator to payment of
attorney’s fees under 31 U.S.C. ss.3730(d). 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 H. This Settlement Agreement does not constitute evidence or an admission by any party of any liability or wrongful
conduct. 
 I. HCA has executed letters of credit in favor of the United States in the total amount of one billion dollars ($1,000,000,000) pursuant to a
February 1999 Letter of Credit Agreement (LOC Agreement). The LOC Agreement is incorporated herein by reference. 
 J. HCA and OIG-HHS have executed a
separate Corporate Integrity Agreement (CIA), which is incorporated herein by reference. 
 K. To avoid the delay, uncertainty, inconvenience, and expense of
protracted litigation of the claims set forth above, the Parties hereby reach a full and final settlement of the claims against HCA pursuant to the Terms and Conditions set forth below. 
 III. TERMS AND CONDITIONS 
 NOW, THEREFORE, in reliance upon the representations contained herein, in consideration of the
mutual promises, covenants, and obligations set forth below, and for good and valuable consideration as stated herein, the Parties agree as follows: 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 1. HCA agrees to pay to the United States and the States $745,000,000.00, plus interest accruing at a simple rate of
6.5% per annum from May 18, 2000 through and including the Payment Date (the Settlement Amount). The “Payment Date” shall be within five (5) days of approval of this Agreement by the United States District Court for the
District of Columbia. HCA agrees to pay the Settlement Amount as follows: 
 (a) HCA agrees to pay $731,367,246.23 plus interest accruing at a simple rate of
6.5% per annum from May 18, 2000 through and including the Payment Date to the United States by electronic funds transfer pursuant to written instructions to be provided by Michael F. Hertz, Director, Commercial Litigation Branch, Civil
Division, United States Department of Justice. The $731,367,246.23 represents the total of the following settlement amounts: $90,016,350 (outpatient laboratories); $395,567,650 (DRG upcoding); $50,000,000 (home health community education);
$90,000,000 (home health management fees); $105,783,246.23 (home health billing). 
 (b) HCA also agrees to pay the States $13,632,753.77, plus interest
accruing at a simple rate of 6.5% per annum from May 18, 2000 through and including the Payment Date in a separate escrow, as designated by the States, for distribution to the individual States upon completion of the separate State
settlement agreements. 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 2. Subject to the exceptions in Paragraph 10 below, in consideration of the obligations of HCA set forth in this
Agreement, conditioned upon HCA’s payment in full of the Settlement Amount, the United States (on behalf of itself, its officers, agents, agencies, and departments) agrees to release HCA together with its current and former parent corporations,
each of its direct and indirect subsidiaries, brother or sister corporations, divisions, current or former owners and affiliates, and the successors and assigns of any of them from any civil or administrative monetary claim the United States has or
may have under the False Claims Act, 31 U.S.C. ss.ss.3729-3733; the Civil Monetary Penalties Law, 42 U.S.C. ss.1320a-7a; the Program Fraud Civil Remedies Act, 31 U.S.C. ss.ss.3801-3812; or the common law theories of payment by mistake, unjust
enrichment, breach of contract, and fraud, for the Covered Conduct. 
 3. On the Payment Date, conditioned upon receipt of the Settlement Amount, the LOC
Agreement is hereby amended as follows: 
 (a) The unconditional guarantee by the Company (as defined in the LOC Agreement) of the Obligations (as defined in
the LOC Agreement) in the form of the Letters of Credit (as defined in the LOC Agreement), and the aggregate amount which may be drawn under the Letters of Credit by the United States, shall be two hundred fifty million dollars ($250,000,000) rather
than one billion dollars ($1,000,000,000). 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 (b) Upon receipt by the United States of any payment made in satisfaction of any of the Obligations following the
Payment Date, whether pursuant to an Actionable Order or Settlement Agreement (as such terms are defined in the LOC Agreement) and including any payment made through a drawing under any Letter of Credit, the unconditional guarantee by the Company of
the Obligations in the form of the Letters of Credit, and the aggregate amount which may be drawn under the Letters of Credit by the United States, shall immediately be reduced dollar-for-dollar by the amount of such payment. Reductions pursuant to
this clause (b) shall be cumulative and in addition to the reduction described in clause (a) above. For purposes of this clause (b), a payment shall be deemed made in satisfaction of an obligation only if acknowledged in writing as such by
the United States or if made through a drawing under a Letter of Credit. 
 (c) In connection with any reduction of the Company’s guarantee of the
Obligations described in clause (a) or (b) above, the Company may elect to replace the then outstanding Letter(s) of Credit with one or more new Letter(s) of Credit in an amount at least equal to the reduced amount of the Company’s
guarantee set forth in clause (a) or (b) (as applicable), so long as the new Letter(s) of Credit are issued by a Letter of Credit issuer acceptable under Paragraph 2 of the LOC Agreement. The replaced Letter(s) of Credit shall be returned
for cancellation to the Company in exchange for the replacement Letter(s) of Credit. 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 HCA and the United States acknowledge that the foregoing agreement to replace the Company’s unconditional
guaranty of the Obligations in the form of the Letters of Credit on the Payment Date with two hundred fifty million dollars ($250,000,000) rather than one billion dollars ($1,000,000,000) is not based on the amount or expected amount of HCA’s
remaining liability for conduct not addressed by this Agreement. 
 4. This Agreement is expressly conditioned upon resolution, through execution of plea
agreement(s) or otherwise, of the Company’s corporate criminal liability, with the Department of Justice (the Criminal Condition) as set forth in the Plea Agreement executed on December 14, 2000. As used in this Paragraph, the term
“resolution” includes, where appropriate, acceptance by the appropriate court(s) of any plea agreement(s) and imposition of any sentence(s) necessary to effectuate the Criminal Condition. 
 5. After the execution of this Agreement, the United States and HCA will move the United States District Court for the District of Columbia for (1) dismissal with
prejudice of the claims against HCA in the Civil Actions identified in Paragraph B (1) - (4) above; and (2) dismissal with prejudice of those claims against HCA in the Civil Actions identified in Paragraph B (5) - (13) above that are
co-extensive with the Covered Conduct. 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 The motions to dismiss will be conditioned upon receipt by the United States of the Settlement Amount. The claims
that the United States and HCA agree are co-extensive with the Covered Conduct are identified in Attachment 5 to this Agreement, incorporated by reference herein. The parties agree that they reserve the right to seek to dismiss any claim of any
relator other than those identified on the grounds they are coextensive with the Covered Conduct or are otherwise barred. The United States also agrees to use reasonable good faith efforts to cause the dismissal or release of any claims filed by
relators (with prejudice to relators but without prejudice to the United States) in the Civil Actions identified in Paragraph B (5) - (13) above that: 1) relate to home health community education claims (as described in Paragraph D
(3) above) submitted to Medicaid, TRICARE or FEHBP; 2) relate to home health billing claims (as described in Paragraph D (4) above) submitted to FEHBP; and 3) relate to home health management fees claims (as described in Paragraph D
(5) above) submitted to Medicaid, TRICARE or FEHBP. 
 6. Should this Agreement be challenged by any relator as not fair, adequate or reasonable
pursuant to 31 U.S.C. ss.3730(c)(2)(B), the United States and HCA agree that they will take all reasonable and necessary steps to defend this Agreement. 
 7. In consideration of the obligations of HCA set forth in this Agreement and the CIA, conditioned upon HCA’s payment in full of the Settlement Amount, the OIG-HHS agrees to 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 
release and refrain from instituting, directing or maintaining any administrative action seeking exclusion from the Medicare, Medicaid, or other Federal
health care programs (as defined in 42 U.S.C. ss.1320a-7b(f)) against HCA under 42 U.S.C. ss.1320a-7a (Civil Monetary Penalties Law), or 42 U.S.C. ss.1320a-7(b)(7) (permissive exclusion for fraud, kickbacks, and other prohibited activities), for the
Covered Conduct, except as reserved in Paragraph 10, below, and as reserved in this Paragraph. The OIG-HHS expressly reserves all rights to comply with any statutory obligations to exclude HCA together with its current and former parent
corporations, each of its direct and indirect subsidiaries, brother or sister corporations, divisions, current or former owners, affiliates, and the successors and assigns of any of them from the Medicare, Medicaid, or other Federal health care
program under 42 U.S.C. ss.1320a-7(a)(mandatory exclusion) based upon the Covered Conduct. 
 8. In consideration of the obligations of HCA set forth in this
Agreement, conditioned upon HCA’s payment in full of the Settlement Amount, TMA agrees to release and refrain from instituting, directing, or maintaining any administrative action seeking exclusion from the TRICARE/CHAMPUS Program against HCA
under 32 C.F.R. ss.199.9 for the Covered Conduct, except as reserved in Paragraph 10, below, and as reserved in this Paragraph. TMA expressly reserves authority to exclude HCA together with its current and former parent corporations, each of 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 
its direct and indirect subsidiaries, brother or sister corporations, divisions, current or former owners, affiliates, and the successors and assigns of any
of them, from the TRICARE/CHAMPUS program under 32 C.F.R. ss.ss.199.9 (f)(1)(i)(A), (f)(1)(i)(B), and (f)(1)(iii), based upon the Covered Conduct. 
 9. In
consideration of the obligations of HCA set forth in this Agreement, conditioned upon HCA’s payment in full of the Settlement Amount, OPM agrees to release and refrain from instituting, directing, or maintaining any administrative action
seeking exclusion from the FEHBP program against HCA under 5 U.S.C. ss.8902a or 5 C.F.R. Part 970 for the Covered Conduct, except as reserved in Paragraph 10, below and except if excluded by the OIG-HHS pursuant to 42 U.S.C. ss.1320a-7(a).

 10. Notwithstanding any term of this Agreement, specifically reserved and excluded from the scope and terms of this Agreement as to any entity or person
(including HCA and Relators) are any and all of the following claims of the United States: 
 a. Any civil, criminal or administrative liability to the United
States arising under Title 26, U.S. Code (Internal Revenue Code); 
 b. Any criminal liability; 
 c. Except as explicitly stated in this Agreement, any administrative liability, including mandatory exclusion from Federal health care programs; 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 d. Any liability to the United States (or its agencies) for any conduct other than the Covered Conduct; 

e. Any claims of the United States based upon such obligations as are created by this Agreement; 
 f. Any claims by FEHBP for the Covered Conduct identified in Paragraph D(3) (home health community education), (4) (home health billing), and (5) (home health management fees) above. 
 g. Any claims by TRICARE/CHAMPUS for the Covered Conduct identified in Paragraph D(3) (home health community education) and (5) (home health management fees) above.

 h. Any claims by the United States or the States relating to the Medicaid Program for the Covered Conduct identified in Paragraph D(3) (home health
community education) and (5) (home health management fees) above. 
 i. Any express or implied warranty claims or other claims for defective or
deficient products or services, including quality of goods and services, provided by HCA; 
 j. Any claims for personal injury or property damage or for
other similar consequential damages arising from the Covered Conduct; 
 k. Any claims of the United States based on a failure to deliver items or services
due (with the exception of home health services that the United States alleges were not provided, as described in Paragraph D(4)); 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 l. Any civil or administrative claims of the United States against individuals (including current or former
directors, officers, employees, agents, or shareholders of HCA). 
 11. HCA has entered into a Corporate Integrity Agreement (CIA) with HHS, attached as
Attachment 6, which is incorporated into this Agreement by reference. HCA will implement its obligations under the CIA immediately upon the execution of this Agreement. 
 12. HCA waives and will not assert any defenses HCA may have to any criminal prosecution or administrative action relating to the Covered Conduct, which defenses may be based in whole or in part on a contention that,
under the Double Jeopardy Clause in the Fifth Amendment of the Constitution, or under the Excessive Fines Clause in the Eighth Amendment of the Constitution, this Settlement bars a remedy sought in such criminal prosecution or administrative action.
HCA agrees that this settlement is not punitive in purpose or effect. Nothing in this Paragraph or any other provision of this Agreement constitutes an agreement by the United States concerning the characterization of the Settlement Amount for
purposes of the Internal Revenue Laws, Title 26 of the United States Code. 
 13. HCA fully and finally releases the United States, its agencies, employees,
servants, and agents from any claims (including attorney’s fees, costs, and expenses of every kind and however denominated) which HCA has asserted, could have asserted, or may assert in the future against the United States, its agencies,
employees, servants, and agents, related to the Covered Conduct and the United States’ investigation and prosecution thereof. 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 14. The Settlement Amount will not be decreased as a result of the denial of claims for payment now being withheld
from payment by any Medicare carrier or intermediary or by FEHBP or TRICARE or any State payer, related to the Covered Conduct; and HCA agrees not to resubmit to any Medicare carrier or intermediary or to FEHBP or TRICARE or any State payer any
previously denied claims related to the Covered Conduct, and agrees not to appeal any such denials of claims. 
 15. HCA agrees to the following: 

(a) Unallowable Costs Defined: HCA agrees that all costs (as defined in the Federal Acquisition Regulations (FAR) 48 C.F.R. ss.31.205-47 and in Titles XVIII and XIX of
the Social Security Act, 42 U.S.C. ss.ss.1395-1395ggg and 1396-1396v, and the regulations promulgated thereunder) incurred by or on behalf of HCA, its present or former officers, directors, employees, shareholders, and agents in connection with:

 (1) the matters covered by this Agreement and any related plea agreement, 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 (2) the Government’s audit(s) and civil and any criminal investigation(s) of the matters covered by this
Agreement, 
 (3) HCA’s investigation, defense, and corrective actions undertaken in response to the Government’s audit(s) and civil and any
criminal investigation(s) in connection with the matters covered by this Agreement (including attorney’s fees and the obligations undertaken pursuant to the CIA incorporated in this Agreement), 
 (4) the negotiation and performance of this Agreement and any Plea Agreement, and 
 (5) the payment HCA makes to the United States pursuant to this Agreement and any payments that HCA may make to relators, are unallowable costs on Government contracts and under the Medicare Program, Medicaid Program, TRICARE Program, and
Federal Employees Health Benefits Program (FEHBP). 
 (All costs described or set forth in this Paragraph 15(a) are hereafter, “unallowable
costs”). 
 (b) Future Treatment of Unallowable Costs: These unallowable costs will be separately estimated and accounted for by HCA, and HCA will not
charge such unallowable costs directly or indirectly to any contracts with the United States or any State Medicaid Program, or seek payment for such unallowable costs through any cost report, cost statement, information statement, or payment request
submitted by HCA or any of its subsidiaries to the Medicare, Medicaid, TRICARE, or FEHBP Programs. 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 (c) Treatment of Unallowable Costs Previously Sought: HCA further agrees that within 60 days of the effective date of
this Agreement it will identify to applicable Medicare and TRICARE fiscal intermediaries, carriers, and/or contractors, and Medicaid, VA and FEHBP fiscal agents, any unallowable costs (as defined in this Paragraph) included in payments previously
sought from the United States, or any State Medicaid Program, including, but not limited to, payments sought in any cost reports, cost statements, information reports, or payment requests already submitted by HCA or any of its subsidiaries, and will
request, and agree, that such cost reports, cost statements, information reports, or payment requests, even if already settled, be adjusted to account for the effect of the inclusion of the unallowable costs. HCA agrees that the United States will
be entitled to recoup from HCA any overpayment as a result of the inclusion of such unallowable costs on previously-submitted cost reports, information reports, cost statements, or requests for payment. Any payments due after the adjustments have
been made shall be paid to the United States pursuant to the direction of the Department of Justice, and/or the affected agencies. The 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 
United States reserves its rights to disagree with any calculations submitted by HCA or any of its subsidiaries on the effect of inclusion of unallowable
costs (as defined in this Paragraph) on HCA or any of its subsidiaries’ cost reports, cost statements, or information reports. Nothing in this Agreement shall constitute a waiver of the rights of the United States to examine or reexamine the
unallowable costs described in this Paragraph. 
 16. HCA agrees to cooperate fully and completely with the United States in any criminal, civil and/or
administrative investigations and proceedings of any present and former officers, directors, employees and agents, and of any parties with whom it had or has a business or professional relationship with respect to the Covered Conduct. HCA will
itself provide information through testimony and/or oral briefings by competent corporate representatives upon request of the United States. HCA will furnish to the United States, upon reasonable request, complete and un-redacted copies of all
non-privileged documents, reports, memoranda of interviews, and records in its possession, custody, or control concerning any investigation of the Covered Conduct which it has undertaken, or which has been performed by others on its behalf, and
agrees that it will not assert any claim of privilege with respect to information requested by the United States to establish the authenticity or evidentiary 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 
foundation for the non-privileged information it has provided. HCA agrees not to impair, and, upon reasonable notice, will encourage, the cooperation of its
directors, officers, employees and agents in any investigation of the Covered Conduct. HCA also agrees to use its best efforts to make available, and encourage the cooperation of, former directors, officers and employees for interviews and
testimony, consistent with the rights and privileges of such individuals in any investigation of the Covered Conduct. The obligations referred to in this Paragraph shall in no way limit HCA’s obligations under any other agreement with the
United States or the States, including, but not limited to, the Plea Agreement that HCA is entering with the United States. 
 17. This Agreement is intended
to be for the benefit of the Parties and the States only, and by this instrument the Parties and the States do not release any claims against any other person or entity, except to the extent specifically provided for in this Agreement. 

18. HCA agrees that it will not seek payment for any of the health care billings covered by this Agreement from any health care beneficiaries or their parents or
sponsors. HCA waives any causes of action against these beneficiaries or their sponsors or responsible parties based upon the claims for payment covered by this Agreement. 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 19. Except as may be expressly provided to the contrary in this Agreement, each party to this Agreement will bear its
own legal and other costs incurred in connection with this matter, including the preparation and performance of this Agreement. 
 20. This Agreement is
governed by the laws of the United States. The Parties agree that the exclusive jurisdiction and venue for any dispute arising between and among the Parties under this Agreement will be the United States District Court for the District of Columbia,
except that disputes arising under the Corporate Integrity Agreement shall be resolved exclusively under the dispute resolution provisions in the Corporate Integrity Agreement and disputes arising under the separate agreements with the States shall
be governed by the relevant provisions of those agreements. 
 21. This Agreement may not be amended except by written consent of the Parties, except that
only HCA and OIG-HHS must agree in writing to modification of the Corporate Integrity Agreement. 
 22. The undersigned individuals signing this Agreement on
behalf of HCA represent and warrant that they are authorized by HCA to execute this Agreement. The undersigned United States signatories represent that they are signing this Agreement in their official capacities and that they are authorized to
execute this Agreement. 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 23. This Agreement may be executed in counterparts, each of which constitutes an original and all of which constitute
one and the same agreement. 
 24. This Agreement is binding on HCA’s successors, transferees, heirs, and assigns. 
 25. This Agreement is effective on the date of signature of the last signatory to the Agreement. Facsimiles of signatures shall constitute acceptable, binding signatures
for purposes of this Settlement Agreement. 

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 THE UNITED STATES OF AMERICA 
  

											
		 	DATED:	 	December 14, 2000	 		 	BY:	 	 /s/ Joyce R. Branda

		 		 		 		 		 	JOYCE R. BRANDA
		 		 		 		 		 	DEPUTY DIRECTOR
		 		 		 		 		 	COMMERCIAL LITIGATION BRANCH
		 		 		 		 		 	CIVIL DIVISION
		 		 		 		 		 	U.S. DEPARTMENT OF JUSTICE

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

											
		 	DATED:	 	12/13/00	 		 	BY:	 	 /s/ LEWIS MORRIS

		 		 		 		 		 	LEWIS MORRIS
		 		 		 		 		 	ASSISTANT INSPECTOR GENERAL
		 		 		 		 		 	 OFFICE OF COUNSEL TO THE
 INSPECTOR
GENERAL

		 		 		 		 		 	OFFICE OF INSPECTOR GENERAL
		 		 		 		 		 	 UNITED STATES DEPARTMENT OF
 HEALTH AND HUMAN SERVICES

		 		 		 		 		 	

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

											
		 	DATED:	 	12/12/00	 		 	BY:	 	 /s/ ROBERT L. SHEPHERD

		 		 		 		 		 	ROBERT L. SHEPHERD
		 		 		 		 		 	DEPUTY GENERAL COUNSEL
		 		 		 		 		 	TRICARE MANAGEMENT ACTIVITY
		 		 		 		 		 	 UNITED STATES DEPARTMENT
 OF
DEFENSE

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

											
		 	DATED:	 	12-13-00	 		 	BY:	 	 /s/ William E. Flynn III

		 		 		 		 		 	WILLIAM E. FLYNN III
		 		 		 		 		 	 ASSOCIATE DIRECTOR FOR
 RETIREMENT AND
INSURANCE
 SERVICE

		 		 		 		 		 	UNITED STATES OFFICE OF
		 		 		 		 		 	PERSONNEL MANAGEMENT

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

											
		 	DATED:	 	12-14-01	 		 	BY:	 	 /s/ E. Jeremy Hutton

		 		 		 		 		 	E. JEREMY HUTTON
		 		 		 		 		 	ASSISTANT INSPECTOR GENERAL
		 		 		 		 		 	FOR LEGAL AFFAIRS
		 		 		 		 		 	UNITED STATES OFFICE OF
		 		 		 		 		 	PERSONNEL MANAGEMENT

 CIVIL AND ADMINISTRATIVE SETTLEMENT AGREEMENT 
 BETWEEN U.S. & HCA 
  

 HCA - The Healthcare Company 
  

											
		 	DATED:	 	12/14/00	 		 	BY:	 	 /s/ Robert A. Waterman

		 		 		 		 		 	ROBERT A. WATERMAN
		 		 		 		 		 	GENERAL COUNSEL
		 		 		 		 		 	HCA
						
		 	DATED:	 	12/14/00	 		 	BY:	 	 /s/ Cathryn L. Sowers

		 		 		 		 		 	CATHRYN L. SOWERS
		 		 		 		 		 	VICE PRESIDENT
		 		 		 		 		 	LITIGATION
		 		 		 		 		 	HCA
						
		 	DATED:	 	12/14/00	 		 	BY:	 	 /s/ Roger S. Goldman

		 		 		 		 		 	ROGER S. GOLDMAN
		 		 		 		 		 	LATHAM & WATKINS
		 		 		 		 		 	COUNSEL FOR HCA
						
		 	DATED:	 	12/14/00	 		 	BY:	 	 /s/ Craig Holden

		 		 		 		 		 	S. CRAIG HOLDEN
		 		 		 		 		 	OBER, KALER, GRIMES & SHRIVER
		 		 		 		 		 	COUNSEL FOR HCA

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}]]